Search

Your search keyword '"Pharmacogenomics -- Health aspects"' showing total 101 results

Search Constraints

Start Over You searched for: Descriptor "Pharmacogenomics -- Health aspects" Remove constraint Descriptor: "Pharmacogenomics -- Health aspects"
101 results on '"Pharmacogenomics -- Health aspects"'

Search Results

1. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Reports Findings in Personalized Medicine (Targeting the DNA Repair Enzyme Polymerase th in Cancer Therapy)

2. Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies

3. Ketamine's pharmacogenomic network in human brain contains sub-networks associated with glutamate neurotransmission and with neuroplasticity

4. Pharmacogenomics can show what your body makes of a drug

5. Study Findings from Department of General Surgery Broaden Understanding of Personalized Medicine (Genome-Wide Identification of a Novel Autophagy-Related Signature for Colorectal Cancer)

6. Researchers from University of Alabama at Birmingham Provide Details of New Studies and Findings in the Area of Antiemetic-Antivertigo Agents (Pharmacogenetics of Postoperative Nausea and Vomiting)

7. Findings from Institute for Cancer Research and Treatment (IRCCS) in Personalized Medicine Provides New Insights (A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer)

8. Studies from Second Hospital of Anhui Medical University Further Understanding of Personalized Medicine (Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital)

9. Investigators from St. James' Hospital Have Reported New Data on Personalized Medicine (The Mitochondrial Genes Bak1, Fis1 and Sfn Are Linked With Alterations In Mitochondrial Membrane Potential In Barrett's Esophagus)

10. Reports on Biosensors from Fujian Medical University Provide New Insights [Hyperbranched Rolling Circle Amplification (Hrca)-based Fluorescence Biosensor for Ultrasensitive and Specific Detection of Single-nucleotide Polymorphism Genotyping ...]

11. Data on Personalized Medicine Reported by Researchers at University of Barcelona (Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report)

12. Reports from Research Laboratory Describe Recent Advances in Depression (Association study of polymorphisms within inflammatory genes and methylation status in treatment response in major depression)

13. Studies from Fudan University Shanghai Cancer Center Update Current Data on Personalized Medicine (Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast ...)

14. New Personalized Medicine Study Findings Have Been Reported from H. Allgayer et al (Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer)

15. Researchers at Pennsylvania State University College of Medicine Target Personalized Medicine (Chimeric antigen receptors: unleashing a new age of anti-cancer therapy)

16. Recent Findings from University of Tehran Has Provided New Information about Personalized Medicine (Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention)

17. Reports Summarize Personalized Medicine Study Results from University of Cambridge (New Drugs and Emerging Therapeutic Targets in the Endothelin Signaling Pathway and Prospects for Personalized Precision Medicine)

19. Global Therapeutic Drug Monitoring (TDM) Market Report 2020: Technologies, Applications, Markets, Drug & Drug Abuse Monitoring, Biological Therapies, Competitive Landscape

20. Global Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies Report 2020: Description of 35 Companies Involved with Their Collaborations in this Area

21. Opening Of An Open Tender For The Supply Of Reactive Machine Systems For The Molecular Diagnosis Of Infections Caused By Sars-cov2 In Real Time Pcr For The Needs Of 12 Months (italy-rome: Diagnostic Systems)

22. Genomind Announces Major Industry-Leading HLA-A Test Innovation on its Comprehensive Mental Health Pharmacogenetics (PGx) Test, Increasing Utility for Tens of Thousands of Clinicians and Patients

23. Green Shield Canada and HBM+ announce positive results from clinical trial of pharmacogenomics-led treatment for patients with mental health conditions

24. Green Shield Canada and HBM+ announce positive results from clinical trial of pharmacogenomics-led treatment for patients with mental health conditions

25. Green Shield Canada invests in GenXys to harness power of pharmacogenomics

26. Green Shield Canada invests in GenXys to harness power of pharmacogenomics

27. Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028

28. Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028 - ResearchAndMarkets.com

29. Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DoA) Study, 2018 to 2028 - Technologies, Applications, Markets, 35 Company Profiles

30. Global Therapeutic Drug Monitoring Industry Insights, 2018-2028: Unmet Needs and Strategies for Development

31. Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies to 2028

32. Department of Biomolecular Sciences Reports Findings in Colon Cancer (Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer ...)

33. Studies from Shanghai Jiao-Tong University in the Area of Antineoplastics Reported (A Molecular Recognition Approach To Synthesize Nucleoside Analogue Based Multifunctional Nanoparticles for Targeted Cancer Therapy)

34. New Findings in Hepatitis C Virus Described by J. Ampuero and Co-Researchers (Pharmacogenetics of ribavirin-induced anemia in hepatitis C)

35. New Hepatitis C Virus Findings from University of Turin Outlined (Pharmacogenetics of ribavirin-induced anemia in HCV patients)

36. Study Results from Tongji University Broaden Understanding of Combination Therapy (An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine)

37. Family Care Path Partners With OneOme To Add Pharmacogenomic Testing To Its Genetic Wellness Program

38. Genomind and DrChrono Expand Collaboration to Improve Mental Health Outcomes With Innovative Technology and Services

39. Therapeutic Drug Monitoring (TDM) Report, 2019: Worldwide Market Analysis (2018-2028) with Profiles on 35 Players

40. World Therapeutic Drug Monitoring Research Report 2019: Focus on Technologies, Markets & Companies, 2018-2028

41. Therapeutic Drug Monitoring Market Report 2019: Integrating Therapeutic Drug Monitoring with Pharmacogenetics for Development of Personalized Medicine

42. Prolaris(r) Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer

43. Prolaris(R) Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer

44. Global Therapeutic Drug Monitoring Markets, 2018-2019 & 2028: Focus on Companies & Technologies with Profiles of 35 Companies

45. Therapeutic Drug Monitoring Technologies, Markets & Companies, 2019 Research Report - ResearchAndMarkets.com

46. Therapeutic Drug Monitoring Technologies, Markets & Companies, 2019 Research Report

47. Myriad Announces Prequel(TM) Prenatal Screen with Expanded Aneuploidy Analysis for all 23 Chromosome Pairs

48. Data on COVID-19 Discussed by Researchers at University of Ferrara (Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19)

49. Study Results from Indiana University School of Medicine Provide New Insights into Personalized Medicine (PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease)

50. Investigators from Research Institute Release New Data on Breast Cancer (Pharmacogenomics toward personalized tamoxifen therapy for breast cancer)

Catalog

Books, media, physical & digital resources